<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160308026961N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-07-04</date_registration>
      <primary_sponsor>Vice chancellor for research of Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>The effect of planned sensory stimulation  on the level of consciousness ,vital signs and Oxygen saturation in patients  in patients admitted to the ICU</public_title>
      <acronym></acronym>
      <scientific_title>The effect of planned sensory stimulation performed by family members and nurses on the level of consciousness ,vital signs and Oxygen saturation  in patients  admitted to Intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-05-10</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>115</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/22222</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients with stratified blocking method (based on the age group with 10 years distance, 16 to 25, 26 to 35, 36 to 45, 46 to 55, and 56 to 65) will be randomly  divided into three groups and within each block, half of the intervening and  half-blind individuals are considered as witnesses to balance the number of participants in each of the groups, Blinding description: In this study, patients and outcome evaluators will be blinded to the study groups.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Patients with head trauma.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group will receive sensory stimulation by a family member every day for 2 hours, from 4 to 5 in the evening and 8 to 9 in the night with 3 hours distance and for 6 days. Sensory stimulation program includes sight, auditory, smell, touch and kinesthetic stimulation. Olfactory stimulating by taking alcohol in front of the patient's nose for 5 seconds, sight stimulating by turning the flashlight on and off in front of the  patient's eyes for 2 seconds,auditory  stimulation by calling the patient's own name, time, place and day near the patient's ear three times,touch stimulating by squeezing and massage and rub the skin with cotton and guas, first, one side of the body and then the other side, kinesthetic  stimulation by moving the joints of the hands and feet, the wrist, the hip joint and shoulder joint by bending and straightening, and alternating up and down the arms and legs 15 times, and each of the stimuli is performed once per hour. Intervention 2: The second intervention group will receive sensory stimulation by researcher every day for 2 hours, from 4 to 5 in the evening and 8 to 9 in the night with 3 hours distance and for 6 days. Sensory stimulation program includes sight, auditory, smell, touch and kinesthetic stimulation. Olfactory stimulating by taking alcohol in front of the patient's nose for 5 seconds, sight stimulating by turning the flashlight on and off in front of the  patient's eyes for 2 seconds,auditory  stimulation by calling the patient's own name, time, place and day near the patient's ear three times,touch stimulating by squeezing and massage and rub the skin with cotton and guas, first, one side of the body and then the other side, kinesthetic  stimulation by moving the joints of the hands and feet, the wrist, the hip joint and shoulder joint by bending and straightening, and alternating up and down the arms and legs 15 times, and each of the stimuli is performed once per hour. Intervention 3: The control group will not receive any sensory stimulation.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The main outcomes of the study will be shared.

When:
6 months

To whom:
If requested, results will be made available to other academic researchers

Conditions:
Collected data is confidential and will not be shared with anyone else

Where to obtain:
To receive the documentation, email send for update manager

How to obtain:
In a 15-day period, the documents will be sent e-mail

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shila Amini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Reza Hospital, Parastar Boulevard</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715847141</zip>
        <telephone>+98 834276301</telephone>
        <email>k.vafaee1360@gmail.com</email>
        <affiliation>Emam Reza Hospital</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kamran Vafaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Emam Reza Hospital, Parastar Boulevard</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715847141</zip>
        <telephone>+98 83 3427 6301</telephone>
        <email>k.vafaee1360@gmail.com</email>
        <affiliation>Emam Reza Hospital</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Visitors are only the main members of the family (father, mother, spouse, child, sister, brother) and their age is over 18 years of age.
Patients  is hospitalized with head trauma (Types of brain hematomas and other lesions, except diffuse axon damage)
The patient has pupil reflexes at the entrance to the ICU section.
The level of patients consciousness be between 6 and 12
The patient already has no history of mental illness, GCS fluctuations within a few days prior to the trauma (the Delirium term in this research)
It has not been more than 3 days passed since the patient's admitted to the Intensive Care Unit</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of admission to a psychiatric hospital
Visitors  younger than 18 years of age</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S09.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Unspecified injury of head</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group will receive sensory stimulation by a family member every day for 2 hours, from 4 to 5 in the evening and 8 to 9 in the night with 3 hours distance and for 6 days. Sensory stimulation program includes sight, auditory, smell, touch and kinesthetic stimulation. Olfactory stimulating by taking alcohol in front of the patient's nose for 5 seconds, sight stimulating by turning the flashlight on and off in front of the  patient's eyes for 2 seconds,auditory  stimulation by calling the patient's own name, time, place and day near the patient's ear three times,touch stimulating by squeezing and massage and rub the skin with cotton and guas, first, one side of the body and then the other side, kinesthetic  stimulation by moving the joints of the hands and feet, the wrist, the hip joint and shoulder joint by bending and straightening, and alternating up and down the arms and legs 15 times, and each of the stimuli is performed once per hour</i_keyword>
      <i_keyword>The second intervention group will receive sensory stimulation by researcher every day for 2 hours, from 4 to 5 in the evening and 8 to 9 in the night with 3 hours distance and for 6 days. Sensory stimulation program includes sight, auditory, smell, touch and kinesthetic stimulation. Olfactory stimulating by taking alcohol in front of the patient's nose for 5 seconds, sight stimulating by turning the flashlight on and off in front of the  patient's eyes for 2 seconds,auditory  stimulation by calling the patient's own name, time, place and day near the patient's ear three times,touch stimulating by squeezing and massage and rub the skin with cotton and guas, first, one side of the body and then the other side, kinesthetic  stimulation by moving the joints of the hands and feet, the wrist, the hip joint and shoulder joint by bending and straightening, and alternating up and down the arms and legs 15 times, and each of the stimuli is performed once per hour</i_keyword>
      <i_keyword>The control group will not receive any sensory stimulation.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The level of consciousness. Timepoint: 10 minutes before the intervention and 30 minutes after the intervention. Method of measurement: Using the Glasgow Coma Scale (GCS).</prim_outcome>
      <prim_outcome>Vital signs. Timepoint: 10 minutes before the intervention and 30 minutes after the intervention. Method of measurement: Using a cardio-respiratory monitoring device and an oxilary thermometer.</prim_outcome>
      <prim_outcome>Arterial oxygen saturation. Timepoint: 10 minutes before the intervention and 30 minutes after the intervention. Method of measurement: Using a cardio-respiratory monitor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research of Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-11-23</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences, Building No.2, Shahid Beheshti, Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
